Features of vulnerable plaques and clinical outcome of UA/NSTEMI: Relationship with matrix metalloproteinase functional polymorphisms.

No abstract is available for this paper.

• Publication year

  2011

• Venue

  Atherosclerosis

• Publication date

  2011-03-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1016/j.atherosclerosis.2010.12.010PMID 21232745
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Matrix metalloproteinase: investigation from gene to protein as effective factor in myocardial infarction

  2010cited by this paper
• Genetic polymorphisms and plasma levels of matrix metalloproteinases and their relationships with developing acute myocardial infarction

  2010cited by this paper
• Effect of matrix metalloproteinase-1 promoter genotype on interleukin-1beta-induced matrix metalloproteinase-1 production in human periodontal ligament cells.

  2010cited by this paper
• Metalloproteinases-2, -9 and TIMP-1 expression in stable and unstable coronary plaques undergoing PCI.

  2008cited by this paper
• Macrophage Apoptosis Exerts Divergent Effects on Atherogenesis as a Function of Lesion Stage

  2008cited by this paper
• The Role of Carotid Plaque Vulnerability and Inflammation in the Pathogenesis of Acute Ischemic Stroke

  2008cited by this paper
• In-hospital outcome of patients with acute coronary syndrome: relationship with inflammation and remodeling markers

  2007cited by this paper
• Redox-dependent Matrix Metalloproteinase-1 Expression Is Regulated by JNK through Ets and AP-1 Promoter Motifs*

  2006cited by this paper
• MMP-9 Microsatellite Polymorphism and Susceptibility to Carotid Arteries Atherosclerosis

  2006cited by this paper
• Regulation of vascular inflammation and remodeling by ETS factors.

  2006cited by this paper
• The role of genetic variants of matrix metalloproteinases in coronary and carotid atherosclerosis

  2006cited by this paper
• Allele-specific MMP-3 transcription under in vivo conditions.

  2006cited by this paper
• Comparison of levels of serum matrix metalloproteinase-9 in patients with acute myocardial infarction versus unstable angina pectoris versus stable angina pectoris.

  2006cited by this paper
• Divergent effects of matrix metalloproteinases 3, 7, 9, and 12 on atherosclerotic plaque stability in mouse brachiocephalic arteries

  2005cited by this paper
• Inhibition of ets, an essential transcription factor for angiogenesis, to prevent the development of abdominal aortic aneurysm in a rat model

  2005cited by this paper
• Matrix metalloproteinase-1 associates with intracellular organelles and confers resistance to lamin A/C degradation during apoptosis.

  2005cited by this paper
• Genetic strategies to elucidate the roles of matrix metalloproteinases in atherosclerotic plaque growth and stability.

  2005cited by this paper
• Haplotype Effect of the Matrix Metalloproteinase-1 Gene on Risk of Myocardial Infarction

  2005cited by this paper
• Proapoptotic Effect of Proteolytic Activation of Matrix Metalloproteinases by Streptococcus pyogenes Thiol Proteinase (Streptococcus Pyrogenic Exotoxin B)

  2004cited by this paper
• Genetic variations of matrix metalloproteinase-1 and -3 promoter regions and their associations with susceptibility to myocardial infarction in Japanese.

  2003cited by this paper
• Pathology of the thin-cap fibroatheroma: a type of vulnerable plaque.

  2003cited by this paper
• Association of a decreased number of d(CA) repeats in the matrix metalloproteinase-9 promoter with glomerulosclerosis susceptibility in mice.

  2002cited by this paper
• ACC/AHA 2002 guideline update for the management of patients with unstable angina and non-ST-segment elevation myocardial infarction--summary article: a report of the American College of Cardiology/American Heart Association task force on practice guidelines (Committee on the Management of Patients

  2002cited by this paper
• Polymorphisms in Matrix Metalloproteinase-1, -3, -9, and -12 Genes in Relation to Subarachnoid Hemorrhage

  2001cited by this paper
• ApoE knockout mice expressing human matrix metalloproteinase-1 in macrophages have less advanced atherosclerosis.

  2001cited by this paper
• ACC/AHA guidelines for the management of patients with unstable angina and non-ST segment elevation myocardial infarction: executive summary and recommendations.

  2000cited by this paper
• Targeted deletion of matrix metalloproteinase-9 attenuates left ventricular enlargement and collagen accumulation after experimental myocardial infarction.

  2000cited by this paper
• Genetic analysis of MMP3, MMP9, and PAI-1 in Finnish patients with abdominal aortic or intracranial aneurysms.

  1999cited by this paper
• Shortened microsatellite d(CA)21 sequence down‐regulates promoter activity of matrix metalloproteinase 9 gene

  1999cited by this paper
• A single nucleotide polymorphism in the matrix metalloproteinase-1 promoter creates an Ets binding site and augments transcription.

  1998cited by this paper
• Interstitial collagenase (MMP-1) expression in human carotid atherosclerosis.

  1995cited by this paper
• Preliminary report: genetic variation in the human stromelysin promoter is associated with progression of coronary atherosclerosis.

  1994cited by this paper
• Increased expression of matrix metalloproteinases and matrix degrading activity in vulnerable regions of human atherosclerotic plaques.

  1994cited by this paper

• Positive impact of nutrition in the prevention of peripheral vascular disease and severe acute respiratory syndrome coronavirus 2: review

  2024cites this paper
• Tryptophan, after inflammatory cytokine stimulation, determines plaque vulnerability and risk of myocardial infarction

  2022cites this paper
• Prospective cohort study reveals MMP-9, a neuroplasticity regulator, as a prediction marker of cochlear implantation outcome in prelingual deafness treatment

  2021cites this paper
• SARS-CoV-2 and Pre-existing Vascular Diseases: Guilt by Association?

  2021cites this paper
• Remodeling of abdominal Aortic Aneurysm Sac following EndoVascular Aortic Repair: Association with Clinical, Surgical, and Genetic factors.

  2021cites this paper
• Multiple sites of vascular dilation or aneurysmal disease and matrix metalloproteinase genetic variants in patients with abdominal aortic aneurysm

  2017cites this paper
• Association of Matrix Metalloproteinase-1 and Matrix Metalloproteinase-3 Gene Variants with Ischemic Stroke and Its Subtype.

  2017cites this paper
• Evidence for the Involvement of Matrix-Degrading Metalloproteinases (MMPs) in Atherosclerosis.

  2017cites this paper
• Human Polymorphisms in Placentally Expressed Genes and Their Association With Susceptibility to Congenital Trypanosoma cruzi Infection.

  2016cites this paper
• Growth Rate of Small Abdominal Aortic Aneurysms and Genetic Polymorphisms of Matrix MetalloProteases-1, -3, and -9

  2015cites this paper
• Effect of Darapladib Treatment on Endarterectomy Carotid Plaque Lipoprotein-Associated Phospholipase A2 Activity: A Randomized, Controlled Trial

  2014cites this paper
• Serum levels and polymorphisms of matrix metalloproteinases (MMPs) in carotid artery atherosclerosis: higher MMP-9 levels are associated with plaque vulnerability

  2014cites this paper
• Matrix metalloproteinase-1 and matrix metalloproteinase-12 gene polymorphisms and the risk of ischemic stroke in a Tunisian population.

  2014cites this paper
• The Complementary Effects of Atorvastatin and Exercise Treatment on the Composition and Stability of the Atherosclerotic Plaques in ApoE Knockout Mice

  2014cites this paper
• Association analysis of USF1 gene polymorphisms and total unstable carotid plaque area in atherosclerotic stroke patients

  2013cites this paper
• Pravastatin inhibits plaque rupture and subsequent thrombus formation in atherosclerotic rabbits with hyperlipidemia.

  2013cites this paper
• Myocardial structure and matrix metalloproteinases.

  2012cites this paper
• Assessment of MMP-9, TIMP-1, and COX-2 in normal tissue and in advanced symptomatic and asymptomatic carotid plaques

  2011cites this paper
• On the sequence‐directed nature of human gene mutation: The role of genomic architecture and the local DNA sequence environment in mediating gene mutations underlying human inherited disease

  2011cites this paper
• Matrix metalloproteinase-1 and matrix metalloproteinase-12 gene polymorphisms and the outcome of coronary artery disease

  2011cites this paper
• Videodensitometric analysis of advanced carotid plaque: correlation with MMP-9 and TIMP-1 expression

  2011cites this paper